Similar articles

• Beta 2-microglobulin modified with the AGE products of the Maillard reaction in dialysis-related amyloidosis.

  Miyata T, Wada Y, Maeda K. Miyata T, et al. Contrib Nephrol. 1995;112:52-64. doi: 10.1159/000424092. Contrib Nephrol. 1995. PMID: 7554993 Review. No abstract available.
• Pathogenesis of dialysis-related amyloidosis.

  Miyata T, Maeda K. Miyata T, et al. Curr Opin Nephrol Hypertens. 1995 Nov;4(6):493-7. doi: 10.1097/00041552-199511000-00006. Curr Opin Nephrol Hypertens. 1995. PMID: 8591057 Review.
• Advanced glycation of beta 2-microglobulin in the pathogenesis of bone lesions in dialysis-associated amyloidosis.

  Miyata T, Sprague SM. Miyata T, et al. Nephrol Dial Transplant. 1996;11 Suppl 3:86-90. doi: 10.1093/ndt/11.supp3.86. Nephrol Dial Transplant. 1996. PMID: 8840320 Review. No abstract available.
• Beta2-microglobulin and renal bone disease.

  Wada T, Miyata T, Sakai H, Kurokawa K. Wada T, et al. Perit Dial Int. 1999;19 Suppl 2:S413-6. Perit Dial Int. 1999. PMID: 10406556 Review.
• Beta-2-microglobulin amyloidosis and osteo-articular pathology of the uremic patient on regular dialysis.

  Brancaccio D, Anelli A, Gallieni M, Padovese P, Coggi G, Uslenghi C. Brancaccio D, et al. Contrib Nephrol. 1990;77:177-86. doi: 10.1159/000418118. Contrib Nephrol. 1990. PMID: 2188786 Review. No abstract available.